Saxenda® is contraindicated in individuals with a private or spouse and children record of MTC and in people with Various Endocrine Neoplasia syndrome type two (Males two). Counsel patients regarding the likely chance of MTC with utilization of Saxenda® and advise them of symptoms of thyroid tumors (eg, a mass within the neck, dysphagia, dyspne